Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

NCT02852239 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: dabrafenib

Sponsor

Novartis Pharmaceuticals